Comments
Dr Reddy’s Laboratories Ltd has re-launched its Esomeprazole Magnesium delayed-release capsules in the US market.
The drug is a therapeutic equivalent generic version of Nexium (esomeprazole magnesium) delayed-release capsules of Astrazeneca AB Corporation.
"The re-launch is due to a change in the capsule colour, the Hyderabad based company said in a release on Wednesday. It is used in the treatment of certain stomach and esophagus disorders.
Dr Reddy’s scrip gained 1.12 per cent on the Bombay Stock Exchange on Wednesday and is trading at Rs 3,137 by the noon.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.